Helena Edlund[Author] - Search Results

Year	Number of Results
2002	3
2003	4
2005	6
2006	2
2007	2
2008	5
2009	4
2011	1
2013	1
2014	1
2015	4
2016	3
2017	2
2018	3
2019	2
2020	1
2021	4
2022	3
2023	1
2024	1

1

Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers.

Berg S, Edlund H, R F Goundry W, A S Bergström C, Davies NM. Berg S, et al. Among authors: edlund h. Int J Pharm. 2022 Nov 25;628:122238. doi: 10.1016/j.ijpharm.2022.122238. Epub 2022 Sep 27. Int J Pharm. 2022. PMID: 36174850 Review.

2

O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving β-cell function.

Norlin S, Axelsson J, Ericsson M, Edlund H. Norlin S, et al. Among authors: edlund h. Commun Biol. 2023 Aug 25;6(1):877. doi: 10.1038/s42003-023-05255-6. Commun Biol. 2023. PMID: 37626210 Free PMC article.

3

Pancreatic organogenesis--developmental mechanisms and implications for therapy.

Edlund H. Edlund H. Nat Rev Genet. 2002 Jul;3(7):524-32. doi: 10.1038/nrg841. Nat Rev Genet. 2002. PMID: 12094230 Review.

4

Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children.

Edlund H, Melin J, Parra-Guillen ZP, Kloft C. Edlund H, et al. Clin Pharmacokinet. 2015 Jan;54(1):35-80. doi: 10.1007/s40262-014-0208-4. Clin Pharmacokinet. 2015. PMID: 25516414 Review.

5

Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignancies.

Edlund H, Buil-Bruna N, Vishwanathan K, Wei H, Raman R, de Kock M, He Z, Liu H, Baek M, Ware J, Patel P, Tomkinson H, Sharma S. Edlund H, et al. Br J Clin Pharmacol. 2022 May;88(5):2284-2296. doi: 10.1111/bcp.15087. Epub 2021 Oct 17. Br J Clin Pharmacol. 2022. PMID: 34532877 Free PMC article.

6

AMPK activator O304 improves metabolic and cardiac function, and exercise capacity in aged mice.

Ericsson M, Steneberg P, Nyrén R, Edlund H. Ericsson M, et al. Among authors: edlund h. Commun Biol. 2021 Nov 18;4(1):1306. doi: 10.1038/s42003-021-02837-0. Commun Biol. 2021. PMID: 34795407 Free PMC article.

7

Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP-5862, in patients with B-cell malignancies and in healthy subjects using a population pharmacokinetic approach.

Edlund H, Bellanti F, Liu H, Vishwanathan K, Tomkinson H, Ware J, Sharma S, Buil-Bruna N. Edlund H, et al. Br J Clin Pharmacol. 2022 Feb;88(2):846-852. doi: 10.1111/bcp.14988. Epub 2021 Aug 21. Br J Clin Pharmacol. 2022. PMID: 34265100 Free PMC article.

8

Increased islet apoptosis in Pdx1+/- mice.

Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H, Polonsky KS. Johnson JD, et al. Among authors: edlund h. J Clin Invest. 2003 Apr;111(8):1147-60. doi: 10.1172/JCI16537. J Clin Invest. 2003. PMID: 12697734 Free PMC article.

9

The ATPase activity of Asna1/TRC40 is required for pancreatic progenitor cell survival.

Norlin S, Parekh V, Edlund H. Norlin S, et al. Among authors: edlund h. Development. 2018 Jan 3;145(1):dev154468. doi: 10.1242/dev.154468. Development. 2018. PMID: 29180572 Free PMC article.

10

Endocrine cell clustering during human pancreas development.

Jeon J, Correa-Medina M, Ricordi C, Edlund H, Diez JA. Jeon J, et al. Among authors: edlund h. J Histochem Cytochem. 2009 Sep;57(9):811-24. doi: 10.1369/jhc.2009.953307. Epub 2009 Apr 13. J Histochem Cytochem. 2009. PMID: 19365093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year